Unibest 优贝德
← Back to patent-cliff list

CAS 123-30-8

4-aminophenol

Codes:CABO-011、SORF-004

Application context (from source-drug indications)

神经内分泌瘤苹果酸卡博替尼胰腺神经内分泌肿瘤苹果酸卡博替尼肾细胞癌苹果酸卡博替尼肝细胞癌苹果酸卡博替尼甲状腺瘤苹果酸卡博替尼神经内分泌癌苹果酸卡博替尼甲状腺瘤甲苯磺酸索拉非尼肝细胞癌甲苯磺酸索拉非尼肾细胞癌甲苯磺酸索拉非尼侵袭性纤维瘤病甲苯磺酸索拉非尼肝癌甲苯磺酸索拉非尼骨髓增生性疾病甲苯磺酸索拉非尼

Source drugs (routes using this intermediate)

DrugTierExpiry
苹果酸卡博替尼Cabozantinib S-malateTier B — Position early2029
甲苯磺酸索拉非尼Sorafenib TosylateTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Unibest Nantong cGMP Site4-Hydroxy-6,7-dimethoxyqunioline
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site4-((6,7-Dimethoxyquinolin -4-yl)oxy)aniline
Pharmaceutical Intermediates
询价询价询价
—
Qualified Partner — East China API Works1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid
Pharmaceutical Intermediates
询价询价询价
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.